Saluda Medical is a global medical device company focused on patient outcomes, science, and engineering to transform the neuromodulation industry with a platform of closed-loop technologies based on the Evoked Compound Action Potential (ECAP).
Saluda's first device, Evoke®, is designed to be the first ECAP-Controlled Closed-Loop Spinal Cord Stimulation (SCS) System.
Evoke measures the spinal cord's response to stimulation (ECAP), adjusts on every pulse to optimize activation within the patient's therapeutic window, and is designed to maintain long-term results through ECAP control.
Evoke is currently under investigation through the first double-blinded, randomized, controlled U.S. pivotal study in SCS.
Evoke has received CE mark in Europe.
Great science produces great outcomes for patients: We look at things differently and are excited by new ideas
You can’t improve what you can’t measure
We love to invent cool stuff
People are the source of our inspiration and innovation
We work as a team, sharing our knowledge and data
We ask “how can we?” instead of saying why it can’t be done
Quality matters to us, in everything we do
We are proud of what we have achieved and excited about what we plan to achieve
We are committed to commercial success and long term profitability to ensure we are always there for patients